McDonough Geoffrey's Insider Trades & SAST Disclosures
McDonough Geoffrey's most recent trade in Generation Bio Co was a trade of 5,274 Restricted Stock Units done . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern McDonough Geoffrey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 5,274 | 36,911 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 5,274 | 1,351,212 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 15 Apr 2025 | 1,548 | 1,349,664 | - | 0.4 | 569 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 5,274 | 42,185 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 5,274 | 1,347,766 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 15 Jan 2025 | 1,828 | 1,345,938 | - | 0.9 | 1,623 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 901,690 | 901,690 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 5,274 | 47,459 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 5,274 | 1,339,177 | - | - | Common Stock | |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. | 15 Oct 2024 | 1,548 | 1,337,629 | - | 2.4 | 3,746 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 5,274 | 1,335,451 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 5,274 | 52,733 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 15 Jul 2024 | 1,548 | 1,333,903 | - | 2.9 | 4,536 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 5,274 | 1,325,006 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 5,274 | 58,007 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Apr 2024 | 1,548 | 1,323,458 | - | 3.7 | 5,728 | Common Stock |
| Third Harmonic Bio Inc | Geoffrey McDonough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 23,437 | 1,314,069 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 23,437 | 0 | - | - | Restricted Stock Units | |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 21,094 | 63,281 | - | - | Restricted Stock Units | |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 21,094 | 1,327,042 | - | - | Common Stock | |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 8,121 | 1,305,948 | - | 1.9 | 15,511 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 7,310 | 1,319,732 | - | 1.9 | 13,962 | Common Stock |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 506,250 | 506,250 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | McDonough Geoffrey | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 240,470 | 240,470 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 23,437 | 46,874 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 23,437 | 1,282,621 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 15 Jul 2023 | 7,476 | 1,275,145 | - | 5.1 | 37,978 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 23,437 | 1,262,947 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 23,437 | 70,311 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 15 Apr 2023 | 6,879 | 1,256,068 | - | 4.5 | 30,956 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 168,750 | 168,750 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 84,375 | 84,375 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 23,438 | 93,748 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 23,438 | 1,247,632 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. | 15 Jan 2023 | 8,122 | 1,239,510 | - | 5.1 | 41,422 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 23,438 | 117,186 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 23,438 | 1,232,724 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 15 Oct 2022 | 10,395 | 1,222,329 | - | 5.6 | 58,316 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 46,876 | 1,223,436 | - | - | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 46,876 | 140,624 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 15 Jul 2022 | 14,150 | 1,209,286 | - | 7.2 | 101,597 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 375,000 | 375,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 187,500 | 187,500 | - | - | Restricted Stock Units | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 35.47 per share. | 03 May 2021 | 8,076 | 1,176,004 | - | 35.5 | 286,456 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 36.32 per share. | 03 May 2021 | 1,924 | 1,174,080 | - | 36.3 | 69,880 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 23 Apr 2021 | 10,000 | 1,184,080 | - | 35.1 | 351,000 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 37.44 per share. | 01 Mar 2021 | 4,321 | 1,198,369 | - | 37.4 | 161,778 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 38.12 per share. | 01 Mar 2021 | 4,289 | 1,194,080 | - | 38.1 | 163,497 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 36.35 per share. | 01 Mar 2021 | 1,390 | 1,202,690 | - | 36.4 | 50,527 | Common Stock |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 251,000 | 251,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jan 2021 | 275,000 | 1,204,080 | - | 0 | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jan 2021 | 275,000 | 275,000 | - | 0 | Common Stock | |
| Generation Bio Co | Geoffrey McDonough | Director, See Remarks, Ten Percent Owner | 16 Jun 2020 | 200,000 | 0 | - | - | Series A Preferred Stock | ||
| Generation Bio Co | Geoffrey McDonough | Director, See Remarks, Ten Percent Owner | 16 Jun 2020 | 113,231 | 1,479,080 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges